Quidel | QDEL - Operating Expenses


Quidel reported $2.04B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Agilent USD 1.42B 57M Sep/2025
Avanos Medical USD 158.83M 69.83M Sep/2025
Becton, Dickinson and Co. USD 5.07B 535M Sep/2025
Bruker USD 776.6M 8.9M Sep/2025
Charles River Laboratories USD 3.41B 2.51B Sep/2025
Danaher USD 5.34B 45.74B Dec/2025
Exact Sciences USD 875.74M 62.51M Sep/2025
Haemonetics USD 136.25M 114.3M Sep/2025
Hologic USD 349.4M 447.1M Dec/2025
Illumina USD 834M 20M Sep/2025
IQVIA Holdings USD 6.16B 2.7B Sep/2025
Merit Medical Systems USD 341.54M 6.11M Sep/2025
Mettler Toledo International USD 735.5M 17.99M Sep/2025
Myriad Genetics USD 229M 3.4M Sep/2025
Neogen USD 230.07M 4.79M Sep/2025
Quidel USD 2.04B 1.42B Sep/2025
Revvity USD 600.61M 12.7M Sep/2025
STAAR Surgical USD 69.04M 8.29M Jun/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Waters USD 2.33B 1.75B Sep/2025